Citation: Ip. Nnane et al., Pharmacokinetic profile of 3 beta-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene (VN/87-1), a potent androgen synthesis inhibitor, in mice, J STEROID B, 78(3), 2001, pp. 241-246
Citation: Dn. Grigoryev et al., Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor, J STEROID B, 75(1), 2000, pp. 1-10
Citation: Vco. Njar et Amh. Brodie, Inhibitors of 17 alpha-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer, CUR PHARM D, 5(3), 1999, pp. 163-180
Authors:
Grigoryev, DN
Long, BJ
Nnane, IP
Njar, VCO
Liu, Y
Brodie, AMH
Citation: Dn. Grigoryev et al., Effects of new 17 alpha-hydroxylase/C-17,C-20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo, BR J CANC, 81(4), 1999, pp. 622-630
Authors:
Grigoryev, DN
Kato, K
Njar, VCO
Long, BJ
Ling, YZ
Wang, X
Mohler, J
Brodie, AMH
Citation: Dn. Grigoryev et al., Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17 alpha-hydroxylase-C-17,C-20-lyase inhibitors, ANALYT BIOC, 267(2), 1999, pp. 319-330